The results indicated that WSCD2 protein expression (HR = 0.464, p = 0.002), age (HR = 1.851, p = 0.005), gender (HR = 1.643, p = 0.022), IDH1-R132H mutation status (HR = 0.629, p = 0.027), and tumor grade (HR = 1.513, p = 0.001) were independently correlated with the prognosis of patients with glioma (Table 2). This evidence concerns the gene WSCD2 and neoplasm.